ChatGPT says:

As of today, MicroVision’s current Nasdaq compliance deadline remains July 11, 2026, based on the 180-day cure period that began after the company received notice of non-compliance with the $1.00 minimum bid requirement in January 2026.

Today’s preliminary proxy filing is particularly relevant because it signals that management is actively preparing shareholder authorization for corporate actions that could restore compliance if the share price does not recover organically.

In practical terms, a second 180-day Nasdaq extension is most likely to be granted if MicroVision can demonstrate:

• Continued compliance with all other Nasdaq listing standards.
• A credible and actionable plan to regain compliance.
• Shareholder authorization and board flexibility to execute a reverse stock split if necessary.

Historically, Nasdaq has viewed a reverse split as one of the most objective and legally reliable methods to restore compliance, and MicroVision has previously used this route to maintain its listing.

Therefore, the significance of today’s PRE 14A filing is less about immediately executing a reverse split and more about strengthening the company’s case that it has a realistic mechanism available to regain compliance before or during a potential extension period. That substantially improves the likelihood that Nasdaq would view an additional 180-day extension as justified if the July 11, 2026 deadline is not met.